Drugs / ASA
last change Aug 2018 re-read 2 minutes ago

ASA

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02239120 Background Nov 2014 → Aug 2018 ischemic stroke Boehringer Ingelheim Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ASA ClinicalTrials.gov intervention name — accepted as the source's own label NCT02239120